Amgen, AstraZeneca’s tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi’s Dupixent

Amgen, AstraZeneca's tezepelumab is looking for a slice of blockbuster asthma market dominated by Sanofi's Dupixent aarmstrong Tue, 05/11/2021 - 14:00

Click to view original post